(DARA) (DARA) Stock Price, News & Analysis

Company Overview

DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company's primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.32 to $0.33
• 52-Week Range: N/A
• Volume: 13,850 shs
• Average Volume: 118,843 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DARA Stock Analysis - Frequently Asked Questions

How were (DARA)'s earnings last quarter?

(DARA) (NASDAQ:DARA) announced its quarterly earnings data on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). The specialty pharmaceutical company had revenue of $1.18 million for the quarter, compared to analysts' expectations of $0.83 million.

What other stocks do shareholders of (DARA) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (DARA) investors own include Castleton Technology (CTP), Richland Resources Ltd (RLD.L) (RLD), Thor Energy (THR), Global Invacom Group (GINV), Legendary Investments (LEG), iPass (IPAS) and Aeterna Zentaris (AEZS).

Company Calendar

• Last Earnings: 11/02/2015
• Today: 5/05/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:DARA
• CIK: 919745
• Web: www.darabiosciences.com
• Phone: +1-816-9147027
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A